- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Onesource Specialty Pharma Limited — Updates, 21-04-2026: Press Release
21-04-2026 | 08:23 am
21-04-2026 | 08:23 am
OneSource's partner secured US approval for a generic Ozempic® (Semaglutide Injection). OneSource serves as the CDMO partner, solidifying its role in manufacturing complex injectables and drug-device combinations.
No comments yet. Be the first to comment!